CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 17, 2021—Oxford Immunotec has released the T-SPOT.COVID test, a CE-marked, ELISpot-based test intended for qualitative detection of T-cell immune response to SARS-CoV-2 in human whole blood.
In a clinical study using samples collected in the U.S., the T-SPOT.COVID test was proven to detect a SARS-CoV-2 cell-mediated immune response in PCR-positive individuals, even with negative serology test results. The test therefore complements results obtained by antibody serology, the company says, to give a more comprehensive view of a person’s adaptive immune response to SARS-CoV-2 infection.
Pages: 1 2